IRCCS Azienda Ospedaliero-Universitaria di Bologna: Breast Neoplasms trials
The registry lists 10 Breast Neoplasms studies with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor. 6 are open to participants now and 0 have results posted.
No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Genetic Markers of Susceptibility to Chemotherapy-induced Ovarian Damage in Cancer Patients Undergoing Ovarian Biopsy for Cryopreservation.RecruitingNCT07270679
- Implementation of Solid Digital PCR to Support Gold-standard Methods for Evaluation of HER2 Amplification Status: Focus on HER2-low SubtypeRecruitingNCT06813456
- Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast CancersRecruitingNCT06800612
- Night-shift Work and Breast CancerRecruitingNCT06786949
- Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral MetabolismRecruitingNCT06773533
- Preoperative Boost Associated With Neoadjuvant Chemotherapy in Luminal B Breast CancerRecruitingNCT05673304Not applicable
- Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer TherapiesStatus unknownNCT04474951Not applicable
- Intensity Modulated Radiotherapy With Concomitant Boost in Breast CancerCompletedNCT03471741
- Modulated Accelerated RAdiotherapy in Early Breast CancerCompletedNCT03461224
- Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PETActive, not recruitingNCT02261389Not applicable